Klingenstein Fields & Co LP
- SEC CIK
- 0000859872
- Latest filing
- Aug 5, 2026
GSK holding history
GSK plc in every 13F filed by Klingenstein Fields & Co LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GSK overviewAll 13F holders of GSKFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −3,731−100.0% | Sold out | Holders |
| Q1 2026 | 3,731 | $205.9K | <0.1% | +3,731 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −6,021−100.0% | Sold out | Holders |
| Q1 2023 | 6,021 | $214.2K | <0.1% | −899−13.0% | Reduced | Holders |
| Q4 2022 | 6,920 | $243.2K | <0.1% | +62+0.9% | Added | Holders |
| Q3 2022 | 6,858 | $202.0K | <0.1% | −153,855−95.7% | Reduced | Holders |
| Q2 2022 | 160,713 | $7.00M | 0.4% | −4,105−2.5% | Reduced | Holders |
| Q1 2022 | 164,818 | $7.18M | 0.3% | −555−0.3% | Reduced | Holders |
| Q4 2021 | 165,373 | $7.29M | 0.3% | −2,199−1.3% | Reduced | Holders |
| Q3 2021 | 167,572 | $6.40M | 0.3% | −3,475−2.0% | Reduced | Holders |
| Q2 2021 | 171,047 | $6.81M | 0.3% | −9,570−5.3% | Reduced | Holders |
| Q1 2021 | 180,617 | $6.45M | 0.3% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.